BMN 349

About BioMarin Pharmaceutical

BioMarin Pharmaceutical is a mission-driven, revenue-generating biotech leader with a 25+ year track record of translating genetic insights into transformative medicines for rare diseases. The company's strategy centers on pursuing 'category-defining' therapies in areas of well-understood biology, leveraging core platforms in enzyme replacement therapy (ERT) and gene therapy. This approach has yielded a commercial portfolio generating significant revenue and a promising clinical pipeline, underpinned by global commercial and manufacturing infrastructure. BioMarin's financial strength and operational maturity support its ambition to sustainably deliver breakthrough science to patients worldwide.

Therapeutic Areas